comparemela.com

Latest Breaking News On - Prakash nagarkatti - Page 12 : comparemela.com

What is the new COVID-19 variant BA 2, and will it cause another wave of infections in the U S ?

COVID-19 pandemic; omicron variant; Delta variant; BA.2 subvariant; coronavirus; vaccine effectiveness; virulence and trasmissibility

South africaPrakash nagarkattiMitzi nagarkattiUniversity of south carolinaSouth carolinaNorthern hemisphere

Prakash Nagarkatti and Mitzi Nagarkatti, Author at The Pulse

Prakash Nagarkatti and Mitzi Nagarkatti, Author at The Pulse
ncpolicywatch.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ncpolicywatch.org Daily Mail and Mail on Sunday newspapers.

South africaMitzi nagarkattiPrakash nagarkattiUniversity of south carolinaSouth carolinaNorthern hemisphere

Mitzi Nagarkatti, PhD, Author at Clinical Advisor

Dr. Mitzi Nagarkatti is SmartState Endowed Chair of Center for Cancer Drug Discovery as well as Carolina Distinguished Professor and Chair of the Dept. of Pathology, Microbiology and Immunology at the School of Medicine (SOM), University of South Carolina (UofSC). In 2005, Dr. Nagarkatti moved from the Medical College of Virginia where she was a Professor in the Dept. of Microbiology and Immunology as well as directed the Immune Mechanisms Program of the National Cancer Institute (NCI)-designated Massey Cancer Center.

Mitzi nagarkattiPrakash nagarkattiUniversity of south carolinaImmunologists prakash nagarkattiSouth carolina

Prakash Nagarkatti, PhD, Author at Clinical Advisor

Dr. Prakash Nagarkatti currently serves as Vice President for Research (VPR) and Carolina Distinguished Professor at the University of South Carolina (USC). In his role as VPR at USC, he oversees research enterprise of ~$280 million. He currently directs three federally-funded Research Centers. He has published ~300 peer-reviewed papers in the areas of inflammation. For his outstanding contributions to science, Dr. Nagarkatti was elected Fellow of American Association for the Advancement of Science (AAAS), Fellow of Academy of Toxicological Sciences (ATS), and a Fellow of the National Academy of Inventors.

Mitzi nagarkattiPrakash nagarkattiUniversity of south carolinaImmunologists prakash nagarkattiSouth carolina

What is the New COVID-19 Variant BA 2, and Will it Cause Another Wave of Infections in the US?

While the origin of BA.2 is still unclear, it has quickly become the dominant strain in many countries, including India, Denmark and South Africa.

South africaPrakash nagarkattiMitzi nagarkattiUniversity of south carolinaSouth carolinaNorthern hemisphereCreative commons

vimarsana © 2020. All Rights Reserved.